China Biologic (CBPO) Gets Approval from China SFDA to Begin Fibrinogen Trials
Go back to China Biologic (CBPO) Gets Approval from China SFDA to Begin Fibrinogen Trials| CHINA BIOLOGIC PRODUCTS, Inc. (NASDAQ: CBPO) | Delayed: 119.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.99 | 52 Week High | $144.29 | |||
| Open | $2.85 | 52 Week Low | $100.53 | |||
| Day High | $119.99 | P/E | 44.44 | |||
| Day Low | $119.99 | EPS | $2.70 | |||
| Volume | 100,698 | |||||
